Hospital
Henry County Hospital INC
Henry County Hospital INC was paid $3.88M by Medicaid between Jan 2018 and Dec 2024, across 107 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoHENRY COUNTY HOSPITAL INC
NAPOLEON, OH 43545
NAPOLEON, OH 43545
33aNPI1407880909assigned 07/10/2006
33bProvider typeCritical Access Hospital
28Total paid$3.88M
24GClaims111,994
24DCodes billed107
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#19 of 26
Median peer was paid$5.33M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,130 | $232K | |
| 2019 | 7,151 | $200K | |
| 2020 | 7,179 | $260K | |
| 2021 | 8,527 | $369K | |
| 2022 | 11,388 | $500K | |
| 2023 | 45,647 | $1.39M | |
| 2024incomplete | 24,972 | $936K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 16,521 | 11,175 | $1.28M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 6,319 | 5,492 | $685K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 4,807 | 4,037 | $543K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 2,464 | 1,774 | $257K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 1,522 | 1,107 | $190K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.6% | 516 | 359 | $140K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.3% | 1,276 | 358 | $90K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 1,328 | 1,082 | $76K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 577 | 466 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 533 | 330 | $67K |
| 80053 | Comprehensive metabolic panel | 1.1% | 5,910 | 4,797 | $43K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 462 | 358 | $40K |
95 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 177 | $39K |
| J3490 | Unclassified drugs | <1% | 9,700 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 156 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,396 | $31K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 171 | $20K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 67 | $16K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,121 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,250 | $14K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,159 | $14K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 333 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,518 | $12K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,745 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,503 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 69 | $11K |
| 80061 | Lipid panel | <1% | 796 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 940 | $10K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 152 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 578 | $8K |
| 84439 | <1% | 412 | $7K | |
| G0378 | Hospital observation service, per hour | <1% | 136 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 391 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 37 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 586 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,226 | $4K |
| 81001 | <1% | 4,450 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 17 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,044 | $3K |
| 85027 | <1% | 711 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 237 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,310 | $2K |
| 84484 | <1% | 1,477 | $2K | |
| 80305 | <1% | 736 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 32 | $2K |
| 85610 | <1% | 446 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 680 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 570 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 101 | $1K |
| 71045 | Radiologic examination, chest; single view | <1% | 888 | $1K |
| 97162 | <1% | 33 | $1K | |
| 82570 | <1% | 138 | $1K | |
| 83874 | <1% | 808 | $954.27 | |
| 86140 | <1% | 94 | $734.80 | |
| 82553 | <1% | 83 | $702.16 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 101 | $625.42 |
| 83735 | <1% | 355 | $597.59 | |
| 87186 | <1% | 303 | $566.72 | |
| 83605 | <1% | 655 | $541.23 | |
| 85007 | <1% | 452 | $465.79 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 39 | $432.44 |
| 82550 | <1% | 803 | $400.22 | |
| 81002 | <1% | 954 | $397.56 | |
| 73630 | <1% | 15 | $364.59 | |
| 82607 | <1% | 25 | $357.32 | |
| 82043 | <1% | 61 | $343.19 | |
| 73562 | <1% | 27 | $339.56 | |
| 90674 | <1% | 18 | $312.20 | |
| 86592 | <1% | 15 | $310.37 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 18 | $296.01 |
| 83690 | <1% | 572 | $289.27 | |
| 80074 | <1% | 15 | $277.79 | |
| 85379 | <1% | 257 | $274.62 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 37 | $233.10 |
| 81025 | <1% | 496 | $222.30 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 840 | $219.40 |
| 88142 | <1% | 31 | $216.33 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,041 | $194.81 |
| 87077 | <1% | 63 | $192.95 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,092 | $189.44 |
| 83540 | <1% | 15 | $182.32 | |
| 87040 | <1% | 231 | $181.87 | |
| 85652 | <1% | 46 | $181.72 | |
| 85730 | <1% | 195 | $158.91 | |
| 83880 | <1% | 142 | $144.55 | |
| 90686 | <1% | 15 | $133.41 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 705 | $71.23 |
| 82150 | <1% | 114 | $53.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,244 | $50.61 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 17 | $39.99 |
| 82962 | <1% | 67 | $36.90 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 353 | $14.47 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 117 | $13.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 373 | $10.04 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 166 | $10.02 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 933 | $8.18 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $1.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 24 | $1.16 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 540 | $0.62 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 146 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 16 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 330 | $0.00 |
| 96376 | 0% | 17 | $0.00 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 15 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 116 | $0.00 |
| 01992 | 0% | 17 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARND, KRISTI (CHIEF EXECUTIVE OFFICER)